FDA Class I Recalls of Dialysis Products for Potential Risk of Serious Injury or Death
Read the full article » | Posted 05-09-2024
Related Articles
- ETC Model Structure Did Not Move the Needle on Home Dialysis with Social Risk Factors Posted 07-12-2024
- New Partnership Will Bring Tablo to 33 States Where US Renal Care has Clinics Posted 05-09-2024
- Tablo-maker Outset Joined the ANNA’s Partnership Advisory Council Posted 05-09-2024
- Watch an Interview with Dialysis Nurse Towanda Maker Posted 04-12-2024